Clinical Trial Update: Chidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide, Etoposide, Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma) [NA]

View source ↗

Summary

A clinical trial investigating chidamide in combination with CHOP for newly diagnosed peripheral T cell lymphoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Chidamide (chidamide)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Peripheral T Cell Lymphoma | NA | Status: UNKNOWN